2023
DOI: 10.1016/j.ijbiomac.2023.126347
|View full text |Cite
|
Sign up to set email alerts
|

Novel soybean polypeptide dglycin alleviates atherosclerosis in apolipoprotein E-deficient mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 36 publications
0
1
0
Order By: Relevance
“…Atherosclerosis is a condition characterized by the accumulation of a lipid layer in the arterial wall, reducing artery elasticity and narrowing the arterial lumen ( Dong et al, 2020 ). Endothelial dysfunction is a leading cause of atherosclerotic plaque and a risk factor for myocardial infarction rupture ( Zhao et al, 2023 ). Zhu and colleagues found that SeQDs can inhibit the activity of Na+/H+ exchanger 1 (NHE1) and impair calcium ion/calpain signaling, effectively improving endothelial cell relaxation, preventing endothelial dysfunction, and limiting the growth of atherosclerotic plaques ( Zhu et al, 2019 ).…”
Section: Biomedical Applicationsmentioning
confidence: 99%
“…Atherosclerosis is a condition characterized by the accumulation of a lipid layer in the arterial wall, reducing artery elasticity and narrowing the arterial lumen ( Dong et al, 2020 ). Endothelial dysfunction is a leading cause of atherosclerotic plaque and a risk factor for myocardial infarction rupture ( Zhao et al, 2023 ). Zhu and colleagues found that SeQDs can inhibit the activity of Na+/H+ exchanger 1 (NHE1) and impair calcium ion/calpain signaling, effectively improving endothelial cell relaxation, preventing endothelial dysfunction, and limiting the growth of atherosclerotic plaques ( Zhu et al, 2019 ).…”
Section: Biomedical Applicationsmentioning
confidence: 99%